Table 1.
Study period | ||||||
---|---|---|---|---|---|---|
Enrolment | Allocation | Post-allocation | Close-out | |||
Timepoint | −t1 | 0 | t1 | t2 | t3 | t4 |
Enrolment | ||||||
Eligibility screen | X | |||||
Informed consent | X | |||||
Allocation | X | |||||
Interventions | ||||||
Povidone-iodine irrigation and topical vancomycin powder | X | |||||
Povidone-iodine irrigation | X | |||||
Assessments | ||||||
Baseline variables age, gender, BMI, presence of hyper-pressure and metabolic syndrome, ASA class |
X | X | ||||
Occurrence of PJI | X | X | X | |||
Occurrence of adverse events and harms | X | X | X | |||
Medical cost analysis | X |
−t1, between admission to the hospital and TKA or THA; t1, TKA or THA; t2, follow-up visits 2 weeks postoperatively; t3, follow-up visits 2 weeks postoperatively; t4, phone contact at 90 days postoperatively